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Crotoxin is a neurotoxin from Crotalus durissus terriﬁcus venom that shows immunomodulatory, anti-
inﬂammatory, antimicrobial, antitumor and analgesic activities. Structurally, this toxin is a hetero-
dimeric complex composed by a toxic basic PLA2 (Crotoxin B or CB) non-covalently linked to an atoxic
non-enzymatic and acidic component (Crotapotin, Crotoxin A or CA). Several CA and CB isoforms have
been isolated and characterized, showing that the crotoxin venom fraction is, in fact, a mixture of
different molecules derived from the combination of distinct subunit isoforms. Intercro (IC) is a protein
from the same snake venom which presents high similarity in primary structure to CB, indicating that it
could be an another isoform of this toxin. In this work, we compare IC to the crotoxin complex (CA/CB)
and/or CB in order to understand its functional aspects. The experiments with IC revealed that it is a new
toxin with different biological activities from CB, keeping its catalytic activity but presenting low myo-
toxicity and absence of neurotoxic activity. The results also indicated that IC is structurally similar to CB
isoforms, but probably it is not able to form a neurotoxic active complex with crotoxin A as observed for
CB. Moreover, structural and phylogenetic data suggest that IC is a new toxin with possible toxic effects
not related to the typical CB neurotoxin.
 2013 Elsevier Masson SAS. All rights reserved.1. Introduction
Snake venoms are complex mixtures of bioactive compounds,
especially proteins and peptides, which serve as weapons for de-
fense and prey capture [1]. Human envenoming caused by snake-
bite accidents is very common in tropical and subtropical regions
worldwide, causing a great impact on public health in developingiglio), andreimar@ﬁocruz.br,
son SAS. All rights reserved.countries [2]. On the other hand, snake venoms constitute a natural
biological source of molecules, which have potential therapeutic
value due to their high afﬁnity and speciﬁcity for critical targets in
cell and tissue organization [3,4].
Snake venom PLA2s (svPLA2s) enzymes/toxins are abundant in
viperid snake venoms, displaying a large array of toxic effects as
neurotoxicity, myotoxicity, cardiotoxicity, cytotoxicity, and impair
effects in blood coagulation and platelet aggregation [5e9]. Part of
these actions is attributed to the enzymatic activity of catalytically
active svPLA2s. However, the presence of some of these toxins
without measurable enzymatic activity [1] evidences the presence
of other toxic sites.
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crotoxin, a neurotoxin found in the Crotalus durissus terriﬁcus
venom [10] which has been implicated in immunomodulatory,
anti-inﬂammatory, antimicrobial, antitumor and analgesic actions
[11]. Structurally, this toxin is a heterodimeric complex composed
by a toxic basic PLA2 (crotoxin B or CB) non-covalently linked to
an atoxic non-enzymatic and acidic component (crotapotin, cro-
toxin A or CA) [12,13]. Several isoforms of both subunits of cro-
toxin have been isolated and characterized [14], showing that the
crotoxin venom fraction is, in fact, a mixture of different mole-
cules derived from the combination of distinct subunit isoforms
[14,15]. In 1975, Laure [16] observed the presence of a new pro-
tein named Intercro (IC), which is eluted between the crotamine
and crotoxin chromatographic peaks, suggesting that this mole-
cule is not associated to the CA subunit in the C. durissus terriﬁcus
venom.
In this work, we describe, for the ﬁrst time, the biochemical
characterization of IC and also performed functional and structural
studies in order to compare this molecule with the crotoxin com-
plex (CA/CB) and/or CB and get insights into its biological aspects.
The results of these analyses indicated that IC is similar to CB iso-
forms. However, it is possible that IC could be a CA-independent
new toxin evolved in toxic functions not related to the typical CB
neurotoxic effects.
2. Material and methods
2.1. IC isolation
C. durissus terriﬁcus venom was obtained from the Serpenta-
rium of the University of São Paulo at Ribeirão Preto School of
Medicine, located in the city of Ribeirão Preto, Brazil. One gram of
the dry venom was dispersed in 5 mL of 0.05 M ammonium
formate buffer (NH4Fo) pH 3.5, and centrifuged at 755 g for
10 min at room temperature (w25 C). The clear supernatant was
then applied to a Sephadex G-75 column (4.5 cm  132 cm)
equilibrated with the same buffer. The elution was performed at a
ﬂow rate of 30 mL/h. Fractions of 10 mL/tube were collected and
monitored at l ¼ 280 nm using an automatic fraction collector.
The fractions were then lyophilized and stored at freezer. The
fraction identiﬁed as Intercro (IC), which was located between
crotoxin and crotamine fractions, was redissolved in the same
buffer and then chromatographed in the same conditions. The
principal peak was harvested, lyophilized and then dissolved in
1 mL of 0.1 M NH4Fo, pH 3.5, and applied to a CM-Cellulose col-
umn (2.5 cm  10 cm) previously equilibrated with this same
buffer. The sample was eluted using a linear gradient (0.1e0.2 M
NH4Fo) at a ﬂow rate of 20 mL/h, and fraction of 5 mL/tube was
collected.
The sample was checked for purity by RP-HPLC using a
4.6 mm  100 mm of a C18 column (4.6 mm  100 mm) (Shi-
madzu), previously equilibrated with solvent A (5%, v/v,
acetonitrile þ 0.1%, v/v, triﬂuoroacetic acid) and then eluted with a
gradient of solvent B (60%, v/v, acetonitrile þ 0.1%, v/v, triﬂuoro-
acetic acid) from 0 to 100%, ﬂow rate ¼ 1.0 mL min1, during
110 min. Elution was carried out at room temperature (25 C) and
fractions were monitored at l ¼ 280 nm.
2.2. Protein estimation
The protein content of the crude venom or fractions was esti-
mated by the micro biuret method as described by Itzhaki and Gil
[17]. The standard curve was drawn with bovine serum albumin,
using an extinction coefﬁcient of 0.660 for 1.0 mg mL1 at
l ¼ 280 nm [18].2.3. Biochemical characterization
2.3.1. Electrophoresis and mass spectroscopy
Determination of Mr was performed by means of SDS-PAGE
according to Laemmli [19], both in the presence and absence of
reducing agents. IC was then analyzed in a mass spectrometer,
triple quadruple electrospray type (Quatmtro II, Micromass, Man-
chester, UK) using a nanoﬂow electrospray origin containing a
fused silica capillary of 20 mm internal diameter, at 2.8 kvolts and
100 C. The sample was introduced by means of a syringe type
pump (Harvard, Inc. USA), at a ﬂow rate of 300 nL min1, the mass
spectra were collected as scan media (15e30 scans) and processed
with MassLynx v.33 software (Micromass, Manchester, UK).
2.3.2. Primary structure
N-Terminal sequence of IC was carried out by means of an
automatic protein microsequenator (Shimadzu PPSQ-21), based on
Edman degradation. Automated protein sequencing was performed
using peptides generated by digestion of IC with trypsin (prote-
omics grade, Promega) and chymotrypsin (Sigma Chem. Co., USA)
in the proportion of 386 pmoles IC/20 pmoles digestive enzyme.
Proteolytic fragments were submitted to RP-HPLC using a Nucleosil
C18 column, (10  250 mm; 5 mm) (Wakosil, Japan), previously
equilibrated with solvent A (5%, v/v, acetonitrile þ 0.1%, v/v, tri-
ﬂuoroacetic acid), and then eluted with a concentration gradient of
solvent B (80%, v/v, acetonitrile þ 0.1%, v/v, triﬂuoroacetic acid)
from 0 to 100%, ﬂow rate ¼ 1.5 mL min1, during 90 min, at 28 C,
monitored at l ¼ 214 nm. Peptides fractions were individually
collected, pooled and concentrated using a speed-vac system; each
tryptic/chymotryptic peptide was individually submitted to amino
acid sequencing as reported above.
2.4. Functional characterization
2.4.1. PLA2 activity upon egg yolk
The radial indirect hemolysis method was used, as described by
Gutiérrez et al. [20], with a single modiﬁcation, in which agar,
instead of agarose, was employed. Gels containing the samples were
incubated at 37 C for 12 h. PLA2 activity was measured through
formation of translucid halos around the points of sample. Halos
were then measured (in mm) for quantiﬁcation of PLA2 activity.
2.4.2. Upon ﬂuorescent lipids
Acyl-NBD was used as substrate [21], ﬁnal volume ¼ 3.0 mL, in a
Hitachi F450 ﬂuorescence spectrophotometer at room tempera-
ture. Excitation and emissionwavelengths were adjusted to 460 nm
and 543 nm, respectively. The standard solution contained 50 mM
TriseHCl and 1 mM CaCl2, pH 7.5. A previous reading A1 of absor-
bance during 2 min was taken with all components, except the
enzyme. Then, the enzymatic activity was started by addition of the
PLA2, thus giving a second reading A2. Reaction was monitored
during 12 min. The readings differences A2eA1 were so deter-
mined. The inﬂuence of cations was investigated in 50 mM Trise
HCl, pH 7.5, replacing Ca2þ by Ba2þ, Cu2þ, Fe2þ, Mg2þ, Mn2þ and
Zn2þ, always at a ﬁnal concentration ¼ 5 mM. For the experiments
carried out in the absence of Ca2þ, 10mM EDTAwas used. The effect
of pH was also evaluated, using different buffers, at pH 3.5 to 12.5.
2.4.3. Neuromuscular blockade
Male Swiss mice were euthanized by exsanguination after cer-
vical dislocation. The phrenic nerve-diaphragm preparations were
removed and mounted vertically in a conventional isolated organ-
bath chamber containing 15 mL of physiological solution of the
following composition (mmol/l): NaCl,135; KCl, 5;MgCl2,1; CaCl2, 2;
NaHCO3, 15; Na2HPO4, 1; glucose, 11. This solutionwas continuously
Table 1
Amino acid sequences of IC homologous proteins.
Protein (identiﬁcation code) Animal species/subspecies GI codea
Protein sequences from snake venoms
N6 basic phospholipase A2 (Bsch) Bothriechis schlegelii 38230125
N6 basic phospholipase A2 (Cgod) Cerrophidion godmani 38230123
Phospholipase A2 3 (Ca3) Crotalus adamanteus 387014170b
Phospholipase A2, basic 9 (Cdc9) Crotalus durissus
cumanensis
313471401
Phospholipase A2, basic 10 (Cdc10) Crotalus durissus
cumanensis
313471402
Phospholipase A2 F6a (CdcF6) Crotalus durissus
collilineatus
239977500
Phospholipase A2 Cdr-12 (Cdr12) Crotalus durissus ruruima 239977492
Phospholipase A2 Cdr-13 (Cdr13) Crotalus durissus ruruima 239977493
Phospholipase A2 F15 (CdtF15) Crotalus durissus terriﬁcus 239977494
Phospholipase A2 F16 (CdtF16) Crotalus durissus terriﬁcus 239977495
Phospholipase A2 F17 (CdtF17) Crotalus durissus terriﬁcus 239977496
Crotoxin CBa2 (Cba2) Crotalus durissus terriﬁcus 129470
Crotoxin CBb (Cbb) Crotalus durissus terriﬁcus c
Crotoxin CBc (Cbc) Crotalus durissus terriﬁcus 48429036
Basic phospholipase A2 Cvv-N6
(CvvN6)
Crotalus viridis viridis 82092667
Phospholipase A2, basic isoform
(Dacu)
Deinagkistrodon acutus 97180272
Phospholipase A2 (Ghal) Gloydius halys 2460027
Phospholipase A2 trimucrotoxin
(Pmuc1)
Protobothrops
mucrosquamatus
26006835
TM-N49 (Pmuc2) Protobothrops
mucrosquamatus
77021843
N6b basic phospholipase A2 (Scat) Sistrurus catenatus
tergeminus
38230127
N6 basic phospholipase A2 (Smil) Sistrurus miliarius streckeri 38230121
Phospholipase A2 (Tﬂa) Trimeresurus ﬂavoviridis 28202237
Protein sequence from Xenopus genus (outgroup sequence)
LOC100145401 protein (Xtrop) Xenopus tropicalis 170285093
a Number identiﬁcation code of the protein sequences in the NCBI data bank.
b Amino acid sequence determined by TSA (Transcriptome Shotgun Assembly).
c Amino acid sequence deduced from electron density map of CBb/CBa2 crotoxin
complex crystallographic structure (PDB ID 1OQS) (Faure et al., 2011).
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isometric force transducer (Grass, FT03) coupled to a signal ampliﬁer
(Gould Systems, 13-6615-50). Indirect contractions were evoked by
supramaximal strength pulses (0.2 Hz; 0.5 ms; 3 V), delivered by an
electronic stimulator (Grass S88K) and applied on the phrenic nerve
by a suction electrode. The results were recorded on a computer
through a data acquisition system (Gould Systems, Summit ACQuire
and Summit DataViewer). The preparationwas stabilized for at least
45 min before the addition of the following components: crotoxin
complex (CA/CB) (10 mgmL1), CB (10 mgmL1), CA (10 mgmL1) and
IC (10 mg mL1). In some experiments, 5 mg mL1of CA were added
45 min after CB (10 mg mL1) or IC 10 (mg mL1). The amplitudes of
indirect twitches were measured during 90 min.
2.4.4. Myotoxic activity
Groups of 5 male Swiss mice (18e25 g) were i.m. injected with
two doses (25 mg and 50 mg) of CB, IC and synthetic peptides dis-
solved in 50 mL of PBS. Controls received only PBS and, 3 h later, the
blood was collected from the tail in heparinized capillaries and
immediately centrifuged. Creatine kinase (CK) activity was evalu-
ated using 4 mL of plasma and the kinetic kit CK-UV (Bioclin, Brazil).
The plasmawas incubatedwith reactant as recommended for 3min
at 37 C and the reaction monitored at A340nm during 3 min as
recommended by kit manufacturer. CK activity was expressed in U/
L, one unit being deﬁned as the result of phosphorylation of one
nmol of creatine/min [22].
2.4.5. Edema induction
Groups of 5 male Swiss mice (18e25 g) were i.d. injected in the
subplantar region of the right paw with 50 mL of IC solution in PBS,
after a previous evaluation of the paw volumes (zero time). The
paws were measured at 30 min, 1 h and 3 h, always subtracting the
volume at zero time. This measure was performed with a low-
pressure pachymeter (Mytutoyo, Japan) and expressed as a % of
induced edema [22].
2.4.6. IC chemical modiﬁcation
Three milligram of IC was dissolved in 1.0 mL of 0.1 M NH4HCO3,
pH 7.0 containing 0.7 mM EDTA. Then, 150 mL of a 0.8 mg mL1
solution of p-bromophenacyl bromide (p-BPB) in ethanol were
added followed by 24 h of incubation at room temperature [22].
Excess reactant was then removed by means of an AMICON YM-3
system, through successive washings with 0.05 M NH4HCO3, pH 8.0.
2.4.7. Analysis of results
The results obtained were expressed as mean  standard de-
viations (SD) and statistically analyzed using the t-student test with
the signiﬁcance levels considered between 0.1 < p < 0.05, with a
conﬁdence interval of 95%.
2.5. Structural and phylogenetic characterization
2.5.1. Dynamic light scattering experiments
Dynamic light scattering (DLS) measurements were performed
with native IC in 20 mM TriseHCl pH 7.0 at 10 C (283 K) and 25 C
(298 K) with a protein concentration of 3.0 mg mL1 using a
DynaPro TITAN equipment (Wyatt Technology). For that, 100
measurements were carried out at each temperature condition and
the results were analyzed using the program Dynamics v.6.10.
2.5.2. Alignment and phylogenetic analysis
IC homologous sequences selected for sequence alignment and
phylogenetic analysis were obtained fromNCBI (The National Center
for Biotechnology Information) database using the BLASTP algorithm
andBLOSUM62substitutionmatrix. Theminimum e-valuepresentedby the selected sequences was 8e113. Multiple sequence alignment
was executed with the program AMAP v.2.2 [23] and the phyloge-
netic tree was build based on the Bayesian method MCMC (Monte
Carlo-Markov chain), using the programMrBayes v.3.1.2 [24,25]. Two
concurrent Markov Chain Monte Carlo (MCMC) runs of 3,000,000
generations were performed using four progressively heated chains,
a heating parameter of 0.2, tree sampling every 1000 generations and
a burn-in setting of 250 trees. The hypothetical phospholipase A2
LOCI100145401 fromXenopus tropicaliswas deﬁned as out-group. All
the IC-homologous sequences used in this study and their respective
identiﬁcation codes are shown in Table 1.
2.5.3. IC modeling and molecular dynamics simulation
Using the HHpred server based alignment [26] (score ¼ 335.27;
sequence identity ¼ 98.0%), the crystallographic model of crotoxin
B (isoform CB2/CBa2) from C. durissus terriﬁcus venom [27] (PDB ID
2qog_chain A) was selected as the ideal template in order to obtain
the theoretical IC structure using program Modeller v.9.10 [28].
Thus, 10 models were initially generated and reﬁned using the
variable target function method (VTFM) with conjugate gradients
(CG) and molecular dynamics (MD) with simulated annealing (SA).
The best theoretical IC model was chosen according to stereo-
chemical and energetic parameters calculated, respectively, with
the programs MolProbity [29] and ProSA-web [30]. Following this
step, the chosen initial theoretical IC model was submitted to MD
simulations using the program GROMACS (Groningen Machine for
Chemical Simulation) v.4.5.3 [31,32]. All simulations were executed
in the presence of explicit water molecules [33] using an Ubuntu
9.04 Linux operational system and eight threads of a dual processor
and quad-core Intel Xeon E5520 CPU (2.27 GHz) with 24 GB of RAM.
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MD simulations and the protonation states of the charged groups
were set to pH 7.0. The minimum distance between any atom in the
models and the box wall was 1.0 nm. An energy minimization (EM)
using a steepest descent algorithm was performed to generate the
starting conﬁguration of the systems. After this step, 200 ps of MD
simulations with position restraints applied to the protein (PRMD)
were executed in order to relax the systems gently. Further 35 ns of
unrestrained MD simulations were calculated in order to evaluate
the stability of the structures. All MD simulations were carried out
in a periodic truncated cubic box under constant temperature
(298 K) and pressure (1.0 bar), which were held constant by
coupling to an isotropic pressure and external heat bath [35]. The
overall structural quality of the theoretical IC structural model
obtained after MD simulation was also checked with the programs
MolProbity and ProSA-web.
3. Results
3.1. IC isolation and sequencing
The chromatographic proﬁle obtained by gel ﬁltration on
Sephadex G-75 (Fig. 1) shows six main peaks, namely as: convulxin,
gyroxin, crotoxin, Intercro (IC), crotamine and smaller peptides. The0,0
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Fig. 1. (A) Gel ﬁltration at room temperature, on Sephadex G-75, of 1 g of C. durissus terriﬁcu
(IC), crotamine, and smaller peptides. The sample was eluted with 0.05 M, pH 3.5 NH4Fo b
matography of 90 mg of crude IC using the same column, under the same conditions, colle
fraction using a CM-Cellulose with a linear concentration gradient of 0.1 Me0.2 M NH4Fo, pH
and III. Insert: SDS-PAGE at 13.5% (w/v) acrylamide. Lanes 1e7 (with reducing agent): 1 emo
(Fraction III CM-Cellulose); 7 e CB. Lanes 8e14 (absence of reducing agent): 8 e crotapotin (
Cellulose); 11, 12, 13 and14-CB.peak containing IC was then applied on the same column under the
same conditions (Fig. 1B), resulting in one peak, which was further
subject to an ion-exchange chromatography (Fig. 1C). At this step,
the fraction III was identiﬁed as IC. The SDS-PAGE analysis under
reducing conditions revealed a single polypeptide with Mr of
14 kDa (Fig. 1C, lane 5). However, three electrophoretic bands were
seenwhen SDS-PAGE is performed in the absence of reducing agent
(Fig. 1C, lane 3). The mass spectrometry analysis of dissociated CB
subunit [36] puriﬁed by a rapid procedure described by Soares et al.
[36] shown a Mr value of 14,246 (Fig. 2A), while free IC shown two
peaks with Mr values of 14,188 and 14,284 (Fig. 2B), which could
correspond to two predominant IC isoforms. The presence of
svPLA2 isoforms belonging the Crotalus genus is a common feature
and is well described in scientiﬁc literature [37,38]. The complete
amino acid sequence of IC is shown in Fig. 3 and its sequential
identity with other svPLA2s in Fig. 4. As attested by highly
conserved residues involved in disulﬁdes bridges and present in the
catalytic site (D42XCCXXHD49) and Ca2þ binding site (X27CGXGG32),
IC could be classiﬁed as member of the PLA2s group II [39].
3.2. Biochemical and functional characterization
CB and IC showed PLA2 activity upon egg yolk at doses of 5 mg
(Fig. 5), but CBwas themost active (Fig. 5A). As seen in Fig. 5A, pBPB0,0
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tivity of fractions was assayed using different ﬂuorescent phos-
pholipids (NBD-PC, NDB-PG, NDB-PA and NDB-PE) (Fig. 5B). NBD-
PC was the best substrate for both enzymes, being CB the most
active enzyme again (Fig. 5B). The optimal pH value for PLA2 ac-
tivity was around 9 for CB and IC (Fig. 5C). The inﬂuence of metal
ions (Caþ2, Mgþ2, Znþ2, Cuþ2, Mnþ2, Feþ2, Baþ2) was analyzed
(Fig. 5D). Ca2þ and Mg2þ ions increased PLA2 activity, which wasn’t
observed for the other ions tested.
IC (10 mg mL1) did not affect the amplitude of indirectly evoked
twitches within 90 min of contact with mice phrenic-diaphragm
preparation (Fig. 6). This ﬁnding contrasts with those observed
for both crotoxin complex (CA/CB) (10 mg mL1), which induced a
progressive depression of the twitch tension until complete block
developed, and CB (10 mg mL1), which caused a slight but signif-
icant blockade of twitches from 45 min onwards. As shown in
Fig. 6B, when CA (5 mg mL1) was added to the organ bath 45 minFig. 2. Mass spectrometry of (A) CB and (B) IC isoforms in a quadrupole electrospray appa
300 nL min1, the mass spectra were collected as scan media (15e30 scans) and processedafter IC (10 mg mL1) there was a discrete facilitation of twitch
amplitude. This effect is in opposition to the synergism of the
neuromuscular blockade observed when CA (5 mgmL1) was added
after CB (10 mg mL1). CA (10 mg mL1) did not alter the amplitude
of twitches. Regarding to myotoxic activity, we observed that CB
was also more active than IC (Fig. 7A). Induced paw edema reached
the maximum 30 min after injection (Fig. 7B).
3.3. Structural studies
Dynamic light scattering (DLS) experiments performed with
native IC in 20 mM TriseHCl, pH 7.0, at 10 C (283 K) revealed a
unimodal molecular distribution (Pd ¼ 9.2%; 99.8% mass) with an
average Mr around 16,000, as calculated from a hydrodynamic
radius (RH) value of 2.1 nm. However, DLS measurements carried
out at 25 C (298 K) indicated the occurrence of dimerization,
which was observed by a broader unimodal molecular distributionratus. The sample was introduced by means of a syringe type pump, at a ﬂow rate of
with MassLynx v.33 software.
Fig. 3. Superposition of the amino acid sequences from tryptic and chymotryptic digestion resulting in the complete IC sequence.
L.F. Vieira et al. / Biochimie 95 (2013) 2365e23752370(Pd ¼ 17.3%; 99.3% mass) with an average Mr around 31,000, as
calculated from a hydrodynamic radius (RH) value of 2.6 nm.
As depicted in Fig. 8, the theoretical IC model after MD simu-
lation keeps the same structural architecture and secondary ele-
ments of the chosen template [27] and other group II PLA2s [37],
presenting seven disulﬁde bonds, an N-terminal a-helix (h1), a
Caþ2-binding loop, two antiparallel a-helices (h2 and h3), a two-Fig. 4. Comparison between the N-terminal sequences from IC and other snake venom A
durissus terriﬁcus, gi:P24027), N6a (Sistrurus c. tergeminus, gi:AAR14164), PLA2 (Sistrurus c.
godmani, gi: AAR14161), PLA2 (Crotalus v. viridis, gi: AAQ13337), PLA-N (Trimereserus ﬂa
(B. jararacussu, gi: P45881). Residues in brown correspond to substitutions in the IC C-termstranded antiparallel-sheet (b-wing), and a long C-terminal loop.
Additionally, the overall structural quality of the MD model could
be considered acceptable, because 95% of its residues were allo-
cated in the allowed regions of the Ramachandran plot [29] and the
Z-score is5.08 [30]. Amore detailed analysis of theMD simulation
also supports the probable adequate stability of the model: be-
tween 10 ns and 35 ns, the amplitude of the backbone atomssp49-PLA2s. CBc/CB1 isoform (C. durissus terriﬁcus, gi: P62022), CBa2/CB2 isoform (C.
catenatus, gi: ABY77918), ATX (Gloydius halys, gi:P14421), N6 basic PLA2 (Cerrophidion
voviridis, gi: Q805A2.2), PLA-N (0) (Trimereserus ﬂavoviridis, gi: BAC56893), BthTX-1
inal sequence.
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Fig. 5. (A) PLA2 activity upon egg yolk of CB, IC and IC þ pBPB (5 and 10 mg); (B) hydrolysis of different ﬂuorescent substrates (5 mM) by CB and IC (45 mg/mL); (C) inﬂuence of pH on
the hydrolysis of NBD-PC by CB and IC (45 mg); (D) effect of divalent cations (8 mM) on the hydrolysis of NBD-PC (5 mM) by CB and IC (45 mg/mL), in the absence or presence of
20 mM EDTA. Results expressed in mean  SD (n ¼ 3).
L.F. Vieira et al. / Biochimie 95 (2013) 2365e2375 2371r.m.s.d. (root mean square deviation) was approximately 2 A.
Furthermore, the comparison of the average backbone atom r.m.s.d.
between the ﬁnal 12.5 ns and the previous 12.5 ns of MD simulation
showed a difference close to 2.0  103, indicating thus a very
similar degree of structural variation of the model along the most
part of the calculation process.
4. Discussion
4.1. IC presents different biological activities compared with CB
isoforms
Snake venom PLA2s (svPLA2s) display signiﬁcant similarities in
their tridimensional structure, although they present awide variety
of pharmacological properties. Due to this, these proteins are
interesting molecular models for the study of structure and
function relationships and physiological/intoxication processes.Therefore, the acquisition of this information could be valuable for
the development of new biotechnological products. In this context,
the study of IC is potentially important, since from the ﬁrst report
by Laure [16] to date this toxin has not yet been isolated and
characterized.
Though at ﬁrst sight, as suggested by a phylogenetic analysis
(Fig. 9B), IC seems to be just a simple CB isoform. The biochemical
assays with IC showed that this toxin, like its homologue CB
molecules, also presents a considerable His48 dependent PLA2ca-
talytic activity, as demonstrated by the blockage of the IC catalysis
induced by pBPB alkylation. CB and IC were also able to hydrolyze
different ﬂuorescent phospholipids, such as PC, PG, PA, and PE,
with a higher speciﬁcity upon phosphatidylcholine (PC) (Fig. 5).
Additionally, the inﬂuence of pH and divalent metal ions on both
enzymes was similar. In contrast, other assayed cations and EDTA
reduced and abolished, respectively, the catalytic activity of the
two toxins.
Fig. 7. (A) Myotoxicity induced by IC and CB. (B) Edema induced by CB, IC (25 and
Fig. 6. (A) Effects of Intercro (IC), PLA2 subunit of crotoxin (CB) and crotoxin (CTX) on
indirectly evoked twitches on mice phrenic-diaphragm muscle preparations.
(B) Inﬂuence of crotapotin subunit of crotoxin (CA) upon the effects of IC and CB. The
ordinate represents the % amplitude of indirectly twitches relative to the initial
amplitude. The abscissa indicates the time (min) after the addition of substances to the
organ bath. Arrow indicates the moment of CA administration. Vertical bars represent
mean  SEM. *Indicates the point from which there are signiﬁcant differences relative
to control (p < 0.05).
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the ﬁrst toxin was clearly more myotoxic in comparison to the last
one (Fig. 7). In addition, differently from the crotoxin complex (CA/
CB association) and CB, IC was not able to affect the neuromuscular
transmission, indicating that IC presents a distinct pattern of bio-
logical activity. Thus, based on these data, it is possible to state that
IC is a new toxin, which keeps an enzymatic activity similar to the
CB isoforms but shows low myotoxicity and a total absence of
neurotoxicity.
4.2. Functional, structural and phylogenetic data indicate a non-
association between CA and IC
According to the functional assays, IC together with or without
CA did not block the neuromuscular transmission, a typical action
of the crotoxin complex and, in a much lower proportion, CB iso-
forms in the absence of CA (Fig. 6). Considering that the efﬁciency of
the crotoxin complex in produce neurotoxic effect depends on the
ability of CA to drive CB to the nerve terminal [40,41], it is possible
to hypothesize that the interaction between IC and CA, if exist, isn’t
able to drive IC to the nerve terminal, as also suggested by the
seminal work of Laure [16] and our chromatographic experiments,
which showed that at pH 3.5 (and range pH 4.5 at 8.0,
Supplemental data), IC was obtained alone and not in a complex
form associated with CA, such as observed for crotoxin complex,
that is found in a stable complex form in range pH 3.5 at 8.0 (Fig. 1A,
Supplemental data). In fact, a structural basis for this supposition
could be proposed based on the comparison of IC with the three CB
isoforms structurally solved to date (CBa2, CBb, and CBc) [15,27] and
also on a phylogenetic analysis involving this toxin and homologue
proteins available in databanks (Table 1).
Despite the presence of highly conserved residues in the N-
terminal a-helix h1, active site region, Ca2þ binding loop, b-wing,
and a-helix h3, there are 11 variable positions between the amino
acid sequences of IC and those of CBa2, CBb and CBc (Fig. 9A). All
these positions correspond to amino acid residues probably placed
on the IC surface, as indicated by the inspection of the theoretical IC
model. This ﬁnding points out that these positions may probably
reveal some insights into structural features of IC. On this regard,
the IC amino acid residues Phe70, Leu117 and Phe120 seem
particularly promising to shed some light on these questions, since
they are exclusively present in the IC sequence whereas the same
positions in the isoforms CBa2, CBb, and CBc are occupied by the
residues Trp70, Tyr117 and Tyr120 (Fig. 9A). Remarkably, Faure
et al. [15] have pointed out that CBb His1 and Trp70 are key resi-
dues involved in the formation of the heterodimer CA2/CBb and
also in other CA/CB associations. In the CA2/CBb crystallographic50 mg) in the mouse paw (18e22 g). Results expressed by mean  SD (n ¼ 5).
Fig. 8. Cartoon representation of the theoretical IC model, highlighting the secondary
structures typically found in group II PLA2s: N-terminal a-helix (h1); Ca2þ binding
loop; two antiparallel a-helixes (h2 and h3); two short antiparallel b-ribbons (b-wing),
and C-terminal loop. Illustration generated by program PyMOL v.1.3 (The PyMOL
Molecular Graphics System, Version 1.3, Schrödinger, LLC).
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residues from CA2 b-chain (including a stabilizing hydrogen bond
with CA2 Asp89), while CBb His1 is essential to keep, via structural
up holding of a neighbor loop (residues 67e71), the appropriateFig. 9. (A) Sequence alignment highlighting the 11 variable positions between IC and th
phylogenetic tree with the IC sequence and homologous sequences generated by the progra
branches and the remaining CB isoforms are nested in the blue branches. The hypothetica
Phylogenetic tree was drawn with the program Mesquite v.2.75 (Maddison and Maddinsonarrangement of the Trp70 side chain. Consequently, based on these
structural ﬁndings, it is possible to infer that the absence of a
neurotoxic active CA/IC complex may be attributed to the presence
of IC mutations His / Ser1 and Trp70 / Phe, which probably
impairs the formation of a stable CA/IC interface. In addition, Faure
et al. [15], based on the CA2/CBb crystallographic model and CBa2,
CBb, and CBc structural superposition, showed that the positions 1
and 70 are also essential to explain the functional differences be-
tween crotoxin classes (class I e high toxicity, low enzymatic ac-
tivity and higher stability; class II e moderate toxicity, high
enzymatic activity and lower stability) [42]. Indeed, residue Ser1 in
class II CA/CBa2 crotoxin complex weakens the stability and toxicity
of this heterodimer due to the signiﬁcant conformational change
(around 9.2 A) of the CBb loop 67e71.
As mentioned above, the orientation change of this CBb loop
leads to the displacement of Trp70, preventing the formation of the
stabilizing hydrogen bond with CA2 Asp89. These experimental
results allow the proposal of a stability level of the crotoxin com-
plexes, where (i) the heterodimers with residues CB His1 and Trp70
are more stable (CBb and CBc isoforms), (ii) the heterodimers with
residues Ser1 and Trp70 present a transitional stability (CBa2 iso-
form), and (iii) the heterodimer is not formed when only the res-
idue Ser1 is present (IC, with the mutations His / Ser1 and
Trp70/ Phe). Furthermore, analysis of a phylogenetic tree with IC
and several homologue svPLA2s proteins strengths the feasibility of
this stability-based hierarchy hypothesis of the Crotoxin hetero-
dimers, since IC and CBa2 are phylogenetically closer when
compared with the isoforms CBb and CBc (Fig. 9B). Thus, the gene
duplications responsible for the emergence of the CB isoformse three CB isoforms structurally solved to date (CBa2, CBb, and CBc); (B) Bayesian
m MrBayes v.3.1.2. IC and the structure-solved CBa2, CBb, and CBc are nested in the red
l phospholipase A2 LOCI100145401 from Xenopus tropicalis was deﬁned as outgroup.
, 2011).
Fig. 10. Clusters on the surface of the IC MD model where the three exclusive IC amino acid residues (Phe70, Leu117, and Phe120) are sited. These IC clusters, which are placed in
opposite sides of the molecule and are formed, respectively, by three (Phe70, Arg74, and Lys92) and four (Asn115, Glu116, Leu117, and Phe120) amino acid residues, could be
important for substrate/molecular recognition and/or oligomerization. Illustration generated by program PyMOL v.1.3 (The PyMOL Molecular Graphics System, Version 1.3,
Schrödinger, LLC).
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stable CA/CB associations, culminating in a CA-independent toxin
with possible toxic effects not related to the typical CB neurotoxic
activity. This apparent paradox, which in principle seems to point to
the selection of isoforms with a moderate toxicity in detriment of
higher toxic complexes, may be explained by the increased toxin
diversity, an efﬁcient evolutionary strategy in the biochemical arms
race between venomous animals and their prey.
Another intriguing issue linked to the questions discussed above
is related to the oligomerization of this toxin. As shown in Fig. 1C, IC
forms molecular aggregates as observed for others PLA2s [43], and
it is mainly dimeric (Mr w28,000); after reduction by mercaptoe-
thanol the toxin is monomeric (Mrw14,600), as reinforced by mass
spectrometry (Mr w14,284). Dynamic light scattering (DLS) ex-
periments conﬁrmed this molecule, in a 3.0mgmL1concentration,
is dimeric at 298 K. This ﬁnding suggests that the molecular di-
versity is also improved by an extra level of oligomerization, with
the potential formation of new molecular-recognition sites not
present in the isolated monomers.
A similar possibility was raised by Marchi-Salvador et al. [27],
who described the tetrameric crystal structure formed by the
combination of two CBa2/CBb dimers. In this work, the authors
hypothesized that the isoforms CBb and CBa2 (identiﬁed respec-
tively as CB1 and CB2) could associate after CA/CB dissociation in
order to generate a quaternary assembly able to identify different
substrates and even increase the toxicity of the CB toxins. In fact,
analysis of the variable positions on the surface of the theoretical
model reveals two IC clusters where the three exclusive IC residues
(Phe70, Leu117, and Phe120) are sited. These IC clusters are placed
in opposite sides of the molecule and are formed, respectively, by
three (Phe70, Arg74, and Lys92) and four (Asn115, Glu116, Leu117,
and Phe120) amino acid residues (Fig. 10). Therefore, it is possible
to suppose that these regions could be important for the IC bio-
logical activities, acting as substrate/molecular recognition regions
on the monomeric and dimeric IC molecular forms and/or as olig-
omerization sites. Furthermore, residue IC Ser1 suggests another
hint related to the possible quaternary assembling of this toxin:
Marchi-Salvador et al. [27] demonstrated that this residue found in
the isoform CBa2 is essential to the stabilization of the dimeric
CBa2/CBc crystal structure, since it forms two salt bridges with CBc
Glu92. Interestingly, the hydrodynamic radii (RH) of the CBa2/CBcassociation and the IC dimeric form are practically identical (2.7
and 2.6 nm, respectively), suggesting that the oligomeric arrange-
ment of both dimers may be very similar. Also, it sounds feasible
not only the oligomerization between IC molecules but also the
quaternary combination of this toxin with CB isoforms.
In conclusion, in spite of the similarity between IC and the CB
isoforms, the results of our analyses indicated that IC is a new snake
venom toxin. The biological activities of this molecule still remain
not completely understood, but the combination of more functional
and structural characterizations could permit the elucidation of this
puzzling question in order to verify our hypothesis proposed here.Acknowledgments
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